Evelo Biosciences, Inc. (EVLO)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
-0.0001 (-20.00%)
Dec 24, 2024, 11:08 AM EST
Evelo Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2016 |
| Net Income | -82.35 | -114.53 | -122.18 | -93.67 | -85.47 | -56.95 | Upgrade
|
| Depreciation & Amortization | 1.56 | 2.06 | 2.22 | 2.03 | 1.76 | 1.94 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.6 | 0.42 | -0.01 | -0.01 | -0 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.16 | - | Upgrade
|
| Stock-Based Compensation | 11.17 | 15.16 | 15.85 | 8.47 | 8.17 | 6.06 | Upgrade
|
| Other Operating Activities | 5.1 | 5.32 | 5.33 | 2.35 | 0.26 | 0.51 | Upgrade
|
| Change in Accounts Payable | -1.05 | 0.17 | 0.16 | 0.84 | -0.59 | -0.22 | Upgrade
|
| Change in Unearned Revenue | - | - | 7.5 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -10.74 | -9.84 | -5.59 | 6.93 | 4.06 | 1.39 | Upgrade
|
| Operating Cash Flow | -73.7 | -101.24 | -96.73 | -73.06 | -71.98 | -47.28 | Upgrade
|
| Capital Expenditures | -0.29 | -0.62 | -1.52 | -1.32 | -3.03 | -5.46 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.56 | - | 0.04 | 0.01 | 0 | 0.17 | Upgrade
|
| Investment in Securities | - | - | - | - | 55 | -54.84 | Upgrade
|
| Investing Cash Flow | 0.27 | -0.62 | -1.48 | -1.32 | 51.97 | -60.13 | Upgrade
|
| Long-Term Debt Issued | - | 44.49 | 14.78 | 10 | 19.48 | 4.98 | Upgrade
|
| Long-Term Debt Repaid | - | -47.61 | - | - | -15 | - | Upgrade
|
| Net Debt Issued (Repaid) | -8.17 | -3.12 | 14.78 | 10 | 4.48 | 4.98 | Upgrade
|
| Issuance of Common Stock | 29.2 | 84.78 | 82.76 | 55.47 | 0.51 | 75.95 | Upgrade
|
| Other Financing Activities | -0.27 | - | - | - | - | -0.25 | Upgrade
|
| Financing Cash Flow | 20.76 | 81.66 | 97.54 | 65.47 | 4.99 | 162.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.52 | -0.45 | - | - | - | - | Upgrade
|
| Net Cash Flow | -52.15 | -20.66 | -0.67 | -8.91 | -15.02 | 54.61 | Upgrade
|
| Free Cash Flow | -73.99 | -101.86 | -98.24 | -74.38 | -75.01 | -52.74 | Upgrade
|
| Free Cash Flow Per Share | -8.67 | -23.37 | -37.14 | -37.68 | -46.84 | -48.23 | Upgrade
|
| Cash Interest Paid | 5.18 | 4.22 | 3.38 | 2.17 | 1.17 | 0.74 | Upgrade
|
| Cash Income Tax Paid | 0.05 | 0.63 | 0.03 | 0.02 | - | - | Upgrade
|
| Levered Free Cash Flow | -43.31 | -61.02 | -61.1 | -40.41 | -46.85 | -32.12 | Upgrade
|
| Unlevered Free Cash Flow | -39.31 | -57.52 | -58.79 | -38.79 | -46.04 | -31.56 | Upgrade
|
| Change in Net Working Capital | 7.23 | 6.32 | 3.21 | -9.47 | -1.04 | -2.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.